Off-Label Communications: A Guide to Sales & Marketing Compliance, 3rd Edition

September 2012

Do you want to make sure that your company or clients understand the complicated FDA regulations for advertising and promoting pharmaceutical products? The third edition of FDLI’s best-selling Off-Label Communications: A Guide to Sales & Marketing Compliance is a comprehensive, practical guidebook on how to comply with the often changing world of off-label regulation, litigation and policy.

This user-friendly resource provides critical updates from industry experts since the release of the second edition in 2009. It includes important, must-read chapters on past and current regulations; civil and criminal penalties of off-label promotion; pitfalls of clinical trials and Medicare and Medicaid reimbursement; product liability risks; and training of sales and marketing personnel. New to the third edition is a chapter focused exclusively on Comparative Effectiveness Research and expanded content on the First Amendment.


Author: Edited by Mark Carlisle Levy
Cover: Softcover
Number of pages: 300 pages
Edition: 3rd
Date published: Sep 21, 2012
ISBN: 978-1-935065-51-7
Language: English


Category   Price
Academic/Student Member   $ 129.00
Academic/Student Non-Member   $ 179.00
Government Member   $ 129.00
Government Non-Member   $ 199.00
Non-Member   $ 219.00
Member   $ 179.00

Bulk Discounts Available